SwePub
Sök i LIBRIS databas

  Utökad sökning

id:"swepub:oai:DiVA.org:kth-80952"
 

Sökning: id:"swepub:oai:DiVA.org:kth-80952" > Short-term antibiot...

Short-term antibiotic treatment has differing long-term impacts on the human throat and gut microbiome

Jakobsson, H E (författare)
Jernberg, C (författare)
Andersson, Anders F. (författare)
Uppsala universitet,Limnologi,Swedish Inst Infect Dis, Dept Bacteriol ; Uppsala Univ, Dept Ecol & Evolut, Evolutionary Biol Ctr
visa fler...
Sjolund-Karlsson, M (författare)
Jansson, Janet (författare)
Swedish University of Agricultural Sciences,Sveriges lantbruksuniversitet,Institutionen för mikrobiologi,Department of Microbiology
Engstrand, L (författare)
Karolinska Institutet
visa färre...
 (creator_code:org_t)
 
2010-03-24
2010
Engelska.
Ingår i: PLOS ONE. - : Public Library of Science (PLoS). - 1932-6203. ; 5:3, s. e9836-
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • Antibiotic administration is the standard treatment for the bacterium Helicobacter pylori, the main causative agent of peptic ulcer disease and gastric cancer. However, the long-term consequences of this treatment on the human indigenous microbiota are relatively unexplored. Here we studied short- and long-term effects of clarithromycin and metronidazole treatment, a commonly used therapy regimen against H. pylori, on the indigenous microbiota in the throat and in the lower intestine. The bacterial compositions in samples collected over a four-year period were monitored by analyzing the 16S rRNA gene using 454-based pyrosequencing and terminal-restriction fragment length polymorphism (T-RFLP). While the microbial communities of untreated control subjects were relatively stable over time, dramatic shifts were observed one week after antibiotic treatment with reduced bacterial diversity in all treated subjects in both locations. While the microbiota of the different subjects responded uniquely to the antibiotic treatment some general trends could be observed; such as a dramatic decline in Actinobacteria in both throat and feces immediately after treatment. Although the diversity of the microbiota subsequently recovered to resemble the pre treatment states, the microbiota remained perturbed in some cases for up to four years post treatment. In addition, four years after treatment high levels of the macrolide resistance gene erm(B) were found, indicating that antibiotic resistance, once selected for, can persist for longer periods of time than previously recognized. This highlights the importance of a restrictive antibiotic usage in order to prevent subsequent treatment failure and potential spread of antibiotic resistance.

Ämnesord

NATURVETENSKAP  -- Biologi (hsv//swe)
NATURAL SCIENCES  -- Biological Sciences (hsv//eng)
MEDICIN OCH HÄLSOVETENSKAP  -- Medicinska och farmaceutiska grundvetenskaper -- Mikrobiologi inom det medicinska området (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Basic Medicine -- Microbiology in the medical area (hsv//eng)

Nyckelord

Anti-Bacterial Agents/*therapeutic use
Case-Control Studies
Clarithromycin/administration & dosage
Drug Resistance
Microbial/genetics
Dyspepsia/drug therapy
Feces
Gastrointestinal Tract/*drug effects/*microbiology
Humans
Metronidazole/administration & dosage
Oligonucleotides/genetics
Omeprazole/administration & dosage
Pharynx/*drug effects/*microbiology
Phylogeny
Polymorphism
Restriction Fragment Length
RNA
Ribosomal
16S/*genetics
Time Factors
MEDICINE
Biology

Publikations- och innehållstyp

ref (ämneskategori)
art (ämneskategori)

Hitta via bibliotek

  • PLOS ONE (Sök värdpublikationen i LIBRIS)

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy